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Thrombosis and restenosis are two major complications associated with current commercial vascular
stents. In situ regeneration of a healthy endothelium has been recognized as a promising strategy to
address these issues. Numerous strategies have been explored for this goal. However, in most of the
cases, they only focused on enhancing endothelial cell growth, ignoring antithrombotic requirements
and the competition between smooth muscle cells (SMCs) and endothelial cells (ECs) for their growth.
This resulted in non-satisfying clinical results. In this study, we created a multifunctional surface that
meets the need of antithrombosis and re-endothelialization. A nanotubular titanium oxide (TiO2) system
has been developed, which elutes the direct thrombin inhibitor, bivalirudin (BVLD); moreover,
polydopamine (PDAM) is used to tailor the surface functionality of TiO2 nanotubes (NTs) for controlling
the elution of BVLD. PDAM-functionalized TiO2 NTs controls the BVLD for more than two months. BVLD
eluted from NTs was bioactive and showed a substantial inhibitory effect on thrombin bioactivity, platelet
adhesion and activation. In addition, the BVLD-eluting nanotubular TiO2 system has high selectivity to
enhance human umbilical vein endothelial cell (HUVEC) growth, while it inhibits human umbilical artery
smooth muscle cell (HUASMC) proliferation. Our design strategy for the BVLD-eluting nanotubular TiO2
system creates a favorable microenvironment for durable thromboresistance and the promotion of re-
endothelialization, and thus it is suitable for the long-term treatment of cardiovascular diseases.1. Introduction
Drug-eluting stents (DES), an important tool with the remarkable
reduction of the restenosis rate,1–3 have been widely used for
treating cardiovascular diseases (CVDs). However, the emergence
of late stent thrombosis (LST)3,4 with fatal outcome seriously
limits their clinical application. Current DES mainly focus on the
inhibition of vascular SMC proliferation, however at the same
time they also suppress EC growth, resulting in a delayed endo-
thelialization.5 The bare stent surface poses the risk of LST.
Vascular endothelium consists of a monolayer of endothelial
cells (ECs) and it is the natural anticoagulant surface of the
blood vessel wall. It is required to maintain vascularerials of Education Ministry, Southwest
hina. E-mail: zhiluyang1029@126.com;
5
Engineering, School of Materials Science
sity, Chengdu, 610031, China
niz Institute of Polymer Research Dresden,
atronics, Southwest Jiaotong University,
tion (ESI) available. See DOI:
hemistry 2014homeostasis and to adjust SMC growth. In situ endothelializa-
tion is widely considered to be essential for the success of stent
implantation.6–8 EC growth, including migration, attachment,
spreading, survival, proliferation and expression of their typical
protein pattern on the vascular stent, plays a crucial role in
arterial treatment and endothelium regeneration. Numerous
strategies have been explored to stimulate a positive reaction of
ECs on a stent surface: Immobilization of bioactive molecules,
such as extracellular matrix (ECM) molecules,9 cell-adhesive
peptides,10 vascular endothelial growth factor (VEGF),11
proteins,12 and cell recognition peptides,13 are popular means to
promote endothelialization. Despite good in vitro results or
short-term clinical performance, the long-term effects of these
stents do not meet the desired ideal effects. Typically, for
instance, the anti-CD34 antibody coated stents have been
reported to show a signicantly enhanced adhesion, in vitro
proliferation of EPCs, and in vivo capture and attachment of
EPCs, however, clinical long-term studies revealed that the anti-
restenotic effects of the coated stents were not as remarkable as
expected.14,15 This limited success is attributed to the focus on
the recruitment of ECs without considering the subsequent
competitive growth of EPCs/ECs with SMCs, therefore resulting
in the formation of an imperfect endothelial layer on the stent,
ultimately the anti-restenosis effect was suboptimal.J. Mater. Chem. B, 2014, 2, 6767–6778 | 6767
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View Article OnlineIdeally, a vascular stent should selectively enhance EC
growth, while actively suppress SMC proliferation and show
good anticoagulant properties. In several recent years, some
researchers, including us, became aware about the impor-
tance of the competitive growth of ECs with SMCs on the
formation of a pure and healthy endothelium on stents,16–20
Some strategies with encouraging results have been explored
to direct EC and SMC fate. The strategies mainly focus on the
immobilization of bioactive peptides or catechols with EC
selectivity, such as Arg-Glu-Asp-Val (REDV) and gallic acid
(GA).16–18 In addition to bioactive molecules, TiO2 nanotube
coating has been demonstrated to be a promising platform for
stent coating with a high selectivity for ECs and suppressing
SMCs.19,20 TiO2 nanotubes enhance EC proliferation and the
secretion of nitric oxide (NO)21 and prostaglandin I2 (PGI2),19
while they suppress SMC proliferation and promote the
expression of smooth muscle a-actin.19 They also show low
immunogenicity through eliciting minimal levels of monocyte
activation and cytokine secretion.22 However, these surfaces
face a common issue, insufficient anticoagulant properties.
Smith et al.23 have reported severe blood clotting at TiO2
nanotube coatings. Further developments are needed to solve
this obstacle for an ideal stent platform. It is noted that in
addition to the desired property of vascular cell selectivity,
TiO2 nanotube coating is also an ideal drug-eluting
system.24,25 The elution of anticoagulant reagents/drugs from
TiO2 nanotube coating may be a possible process to address
the issue of poor hemocompatibility of TiO2 nanotube
coating.
In this work, for the development of an ideal TiO2 nanotube
coating-based stent platform, the direct thrombin inhibitor,
bivalirudin (BVLD, 2180 Da, Fig. S1†) was chosen as eluted
anticoagulant due to its excellent anticoagulant property (good
inhibition for both circulating and clot-bound thrombin, as well
as inhibition in thrombin-mediated platelet activation and
aggregation),26–28 safety (no risk for heparin induced thrombo-
cytopenia HIT II)29 and its appropriate hydrodynamic radius
(<10 nm) for loading into the TiO2 nanotubes (70–90 nm).
Stenting is associated with a complex pathobiological
response. The vessel wall injury at stent implantation causes
thrombus formation, followed by leukocyte accumulation,
inammation, SMC migration and vessel wall remodeling. The
healing usually involves a long process. Therefore, to be clini-
cally useful, drug release from stents should be in sufficient
amounts and last for an extended period of time. Herein, we
present a versatile route for increasing the loading capacity of
BVLD and extending the duration of BVLD release based on
mussel-inspired surface chemistry. Mussel-inspired polydop-
amine (PDAM) coating has drawn considerable attention due to
its good adhesion strength virtually for all the types of surfaces
and secondary reactivity for anchoring or adsorbing biomole-
cules.30 In this investigation, a thin ad-layer of PDAM was
deposited on TiO2 nanotube arrays to tailor its surface func-
tionalities for moderating a controllable loading and release of
BVLD (Fig. 1). Systemic biocompatiblity evaluation of platelet
adhesion and growth behavior of ECs and SMCs were further
performed.6768 | J. Mater. Chem. B, 2014, 2, 6767–67782. Experimental
2.1 Fabrication and characterization of TiO2 nanotube
arrays
TiO2 nanotube arrays were fabricated by anodic oxidation in an
electrolytic solution mixture of glycerol and water (4 : 1, v/v)
containing 0.5 wt% NH4F and 0.35 wt% NaCl. A titanium foil
(0.25 mm thick) was anodized at a constant direct current
voltage of 25 V for 4 h. Aer cleaning the as-prepared nanotube
arrays by distilled water, they were annealed in air at a
temperature of 450 C for 6 h. The obtained TiO2 nanotube
arrays were further cleaned by ethanol and distilled water
before they were used in surface analysis and sterilized with
75% ethanol and UV prior to their use in cell experiments. Field
emission SEM (JSM-6390, JEOL, Japan), X-ray diffractometry
(XRD, X'Pert Pro MPD), XPS (Perkin Elmer 16PC) and Drop
Shape Analysis DSA100 (Krüss, Hamburg, Germany) were used
to characterize the surface morphology, crystal structure,
surface elemental compositions and WCA of the samples,
respectively.
2.2 PDAM surface modication
The TiO2 nanotube arrays were in advance treated by oxygen-
plasma for 1 min. Subsequently, the specimens were ultrason-
ically immersed into 0.5 mg mL1 dopamine hydrochloride
Tris-based buffer solution (1.2 mg mL1, pH 8.5) for 12 h at a
constant temperature of 20 C. The PDAM-modied TiO2
nanotube arrays were then ultrasonically cleaned in distilled
water and dried before use.
2.3 BVLD loading and release
1 cm  1 cm TiO2 nanotube arrays, before and aer PDAM ad-
layer modication and the control at Ti pieces were treated
with oxygen plasma for 1 min before BVLD loading. Subse-
quently, 30 mL of BVLD (10 mg mL1) in deionized (DI) water
was applied to each surface and then exposed to ultrasound for
several seconds to enhance wetting and remove air bubbles.
About 30 mL BVLD solution was then repeatedly added to each
surface. The specimens were air dried in a chemical hood, and
the loading procedure was repeated twice for BVLD. The loaded
specimens were respectively immersed into phosphate buffer
solution (PBS, pH 7.4) and DI water for removing the unbound
BVLD.
The BVLD release from the abovementioned samples was
determined in PBS (pH 7.4). The samples were immersed in
airtight centrifuge tubes with 6 mL PBS and incubated at 37 C
under constant rotation (90–95 rpm). Samples of the elution
medium were removed at specied intervals by removing half
volume of PBS and replacing it with the equal volume of fresh
PBS. The BVLD-loading content was measured photometrically
at 274 nm using a UV-vis Spectrophotometer (UV-2550, Shi-
madzu, Japan) and calibrated with standards of dened
concentrations. The total amount of BVLD loaded to the
samples was determined by ultrasonic elution to the medium.
The eluted medium was taken by removing the entire volume of
3 mL PBS aer ultrasonic treatment (3 times, 5 min) andThis journal is © The Royal Society of Chemistry 2014
Fig. 1 Scheme of the procedure for BVLD loading: (A) bare TiO2 nanotube arrays, (B) surface modification of TiO2 nanotube arrays by PDAM, (C)
BVLD loading and (D) the possible coupling manners of loaded BVLD on PDAM-modified TiO2 nanotube arrays.
Paper Journal of Materials Chemistry B
Pu
bl
is
he
d 
on
 1
1 
A
ug
us
t 2
01
4.
 D
ow
nl
oa
de
d 
by
 S
L
U
B
 D
R
E
SD
E
N
 o
n 
11
/4
/2
01
9 
10
:2
2:
00
 A
M
. 
View Article Onlinereplacing it with fresh PBS every time. The procedure was
repeated until there was no absorbance observed for the eluted
medium at 274 nm.
2.4 Thrombin adsorption and activity
For the test of thrombin adsorption, a chromogenic method was
used.31 In brief, the surfaces were equilibrated with Tris–BSA
buffer (50 mM Tris, 100 mMNaCl, 0.2% BSA, pH 7.4) for 30 min
to avoid non-specic adsorption. Aer removing Tris–BSA
buffer from the samples, 60 mL of 0.2 mg mL1 thrombin in
Tris–BSA buffer was placed on each surface. Aer incubation for
1 h at 37 C, 10 mL supernatant was taken and diluted with 90 mL
Tris–BSA buffer and it was then added to 100 mL chromogenic
substrate (250 mM S-2238 (H-D-Phe-Pip-Arg-pNA$2HCl in Tris–
BSA)). The thrombin activity was then determined at 405 nm in
a kinetic chromogenic assay with S2238 substrate against
standards of dened thrombin concentrations. The amount of
thrombin adsorbed on each sample is considered to be equal to
thrombin consumption in the supernatant.
The chromogenic method was also used to test thrombin
activity. The detailed method has been previously described.32
2.5 Platelet adhesion test
Platelet rich plasma (PRP) was prepared by centrifuging (1500
rpm, 15 min) fresh human whole blood. 50 mL of fresh PRP was
distributed on the samples (1 cm  1 cm) and incubated for 2 h
at 37 C in humidied air. Aer washing with 0.9% NaCl solu-
tion, they were xed using 2.5% glutaraldehyde solution for 12
h, and then again washed with 0.9% NaCl. Aer that the spec-
imens were step-by-step dehydrated in 50, 75, 90 and 100%
ethanol solutions and were then dealcoholized in 50, 75, 90 and
100% isoamyl acetate solutions. Aer critical point drying, the
obtained samples were inspected by SEM. Immunouorescence
of platelet P-selectin was used for the evaluation of plateletThis journal is © The Royal Society of Chemistry 2014activation; the detailed experimental procedure has been
described elsewhere.32
2.6 HUVEC and HUASMC culture
HUVECs and HUASMCs were derived from human umbilical
vein and arteries. The detailed processes of cell culture are
described elsewhere.32
2.7 HUASMC adhesion and proliferation
In brief, HUASMCs were seeded on the specimen surfaces at a
density of 5  104 cells per cm2 for 2 h, 1, 3 and 5 days
respectively. Here, rhodamine 123 staining was performed to
analyze the morphology of the cells. Cell Counting Kit-8 (CCK-8)
was used to evaluate cell proliferation, as described in detail
elsewhere.33
2.8 HUVEC adhesion and proliferation
Actin immunostaining of HUVECs was used for analyzing the
cell morphology, and Cell Counting Kit-8 (CCK-8) was used to
measure cell proliferation, the cell culture time was 2 h, 1 and 3
days, respectively. The cell tests and statistical analysis of cell
morphology are described in detail elsewhere.32
2.9 NO release of adherent HUVECs
NO release by ECs is a very important indicator of the function
of ECs. Here, a common method of Griess reagent was used to
determine the release level of NO produced by HUVECs. In
brief, the specimens were rst cultured in a medium containing
HUVECs at high density of 5  105 cells per cm2 for 8 h to
rapidly form a dense cell monolayer that mimicked the natural
endothelium. Subsequently, the specimens with a conuent cell
monolayer were transferred to new culture plates, and cultured
for 6, 12 and 24 h, respectively. Finally, the cell culture mediumJ. Mater. Chem. B, 2014, 2, 6767–6778 | 6769
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View Article Onlinewas collected, centrifuged and the supernatant was mixed with
an equal volume of Griess reagent (40 mg mL1, Sigma) and
measured at 450 nm. The detailed experimental procedure is
described elsewhere.32
2.10 Migration assays of HUVECs and HUASMCs
The enhancement in EC migration and the inhibition in SMC
migration are crucial for in situ regeneration of a pure and
healthy EC layer on a vascular stent. In this work, both HUVEC
and HUASMC migration assays were performed. As the
commonly used migration assay based on the scarication of
the endothelial layer damages the so coating, a new method
was developed in our previous work.32 Briey, cells were seeded
only on one arm of an L-shaped sample, such that a monolayer
with a sharply dened edge was achieved. Aer that the sample
was turned and the growth of the cells on the other arm of the
sample was documented. Thus, this method was used to
determine the HUASMC and HUVEC migration.
2.11 Co-culture of HUVECs and HASMCs
The co-culture of HUVECs and HASMCs was performed to
evaluate the competitive adhesion behaviors of the two cell
types. Before the preparation of culture, HUVECs were labeled
with CellTracker Green CMFDA, and HASMCs were labeled with
Orange CMTMR according to the product instructions (Molec-
ular Probes, USA). The HUVECs and HASMCs suspensions were
thenmixed in a volume ratio of 1 : 1 and the cells were seeded at
a density of 5  104 cells per cm2. The competitive cell adhesion
was examined aer 2 h incubation. The detailed experimental
procedure is described elsewhere.18
2.12 Statistical analysis
All cell experiments were performed at least in duplicate, and
quantied with at least 4 replicates. The data were presented as
mean  standard deviation (SD) and statistically analyzed by a
one-way ANOVA using the IBM SPSS Statistics 19 soware. The
value of p less than 0.05 represents statistically signicant
difference.
3. Results and discussion
Previous studies have demonstrated that anatase TiO2 nano-
tube arrays with a diameter of 70–90 nm and length of aboutFig. 2 SEM images of TiO2 nanotubes. (A) The top surface showing th
supporting TiO2 nanotube layer; (C) surface topology structure of TiO2
6770 | J. Mater. Chem. B, 2014, 2, 6767–67781 mm are benecial for cell growth and controlled drug
release.20,22,24,25 In this work, TiO2 nanotube arrays with this style
(Fig. 2A and B and S2†) were fabricated by anodic oxidation in a
NH4F aqueous solution. PDAM coating was achieved by
immersion in a dopamine HCl solution. To evaluate the inu-
ence of PDAM deposition on the surface morphology of the TiO2
nanotube arrays, scanning electron microscope (SEM) charac-
terization was performed. The SEM images (Fig. 2C) demon-
strate the obvious morphological changes of the TiO2 nanotube
arrays aer the deposition of PDAM, which typically embodied a
reduced pore diameter of the nanotubes and the adhesion of
some polymer particles.
To demonstrate the successful modication of TiO2 nano-
tube arrays by PDAM, water contact angle (WCA) and X-ray
photoelectron spectroscopy (XPS) measurements were carried
out. As shown in Fig. S3† and Table S1,† the deposition of PDAM
resulted in signicant changes both in WCA and the chemical
composition of TiO2 nanotube arrays. As-deposited PDAM on
any at substrate material shows WCA close to 50.30,34,35 The
deposition of PDAM on the TiO2 nanotube arrays increased the
WCA from close to 0 to about 30 (Fig. S3†). The XPS analysis
revealed the substantial decrease of the titanium signal specic
to TiO2 nanotube arrays and the presence of characteristic
element nitrogen of dopamine (Table S1†). This indicates the
formation of a thin polydopamine lm on the TiO2 nanotube
arrays. In addition, loading with BVLD also led to signicant
changes in both WCA (Fig. S3†) and chemical composition
(Table S1†).
In order to understand the inuence of the PDAM ad-layer
on the elution kinetics, the control TiO2 nanotube arrays (NTs),
PDAM-modied TiO2 nanotube arrays (PDAM/NTs) as well as
at titanium (Flat Ti) were loaded with BVLD by immersion in a
BVLD solution, using ultrasound energy for better diffusion into
the pores. We found that the control NTs showed good loading
capacity of BVLD (Table S2†). The PDAM ad-layer modication
to NTs led to a signicant 162% increase in total mass of BVLD
loading (Table S2†), the total mass of BVLD loaded on PDAM/
NTs reached 276.6  9.8 mg cm2. The increased mass of BVLD
loaded on the NTs is attributed to the PDAM ad-layer. In addi-
tion, BVLD that was loaded into the large gaps between the
tubes of the control NTs was appearing to be stripped off during
the washing step as compared with the PDAM/NTs. Moreover,
the smaller diameter of the nanotube of PDAM/NTs and the
interactions of the phenolic hydroxyl group/amine groups ofe TiO2 nanotube structure; (B) typical cross-sectional image of self-
nanotube after deposition of PDAM coating.
This journal is © The Royal Society of Chemistry 2014
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View Article OnlinePDAM/NTs and loaded-BVLD (Fig. 1) may explain the lower
BVLD loss during the rinsing step.
The BVLD release characteristics of the Flat Ti, NTs and
PDAM/NTs are further compared by photometric determination
of the released peptide (Fig. 3). Obviously, the release proles
are signicantly different for the three sample types. The PDAM/
NTs provided not only more BVLD elution (Fig. 3A) but also a
considerably longer release prole (Fig. 3B) as compared with
the NTs and at Ti. Moreover, the PDAM/NTs released the
lowest fraction of the loaded BVLD (Fig. 3B). The half-life of
BVLD release (t1/2) of the Flat Ti and NTs was only about 10 days,
whereas the t1/2 of the PDAM/NTs reached 35 days. Aer
continuous elution for 70 days, the control NTs released about
84.5% of loaded BVLD, while only 70.5% of loaded BVLD was
released from PDAM/NTs. This revealed that the reduced pore
diameter of the nanotubes aer PDAM ad-layer formation and
the existence of the phenolic hydroxyl and amine groups of
PDAM coating play an important role not only in increasing
BVLD loading but also in prolonging the BVLD release. These
unique advantages of PDAM/NTs in the durable and control-
lable elution of BVLD provide the potential for application in
long-term implanted devices.Fig. 3 BVLD elution for flat Ti, NTs and PDAM/NTs (the size of sample:
1 cm  1 cm, n ¼ 8) after loading with BVLD and brief washing of
unbound substance. (A) Absolute BVLD release; PDAM/NTs release
highest amount of BVLD, and there is still ongoing release after 70
days. (B) BVLD release in terms of the percentage of the loaded
amount. After 70 days, the PDAM/NT system has released only 60% of
the initially loaded drug.
This journal is © The Royal Society of Chemistry 2014Thrombin plays an essential and important role in the coag-
ulation process. Thrombin not only activates the coagulation
factors XI, VIII, V and I (brinogen) in the blood coagulation
pathway, but as part of its activity thrombin also promotes
platelet activation and aggregation via the activation of protease-
activated receptors on the cell membrane of the platelet. The
direct thrombin inhibitor bivalirudin directly inhibits thrombin
by specically binding to both the anion-binding exosite 1 and
the catalytic site of both brin-bound and circulating thrombin.27
Immobilization of BVLD on a material was demonstrated to be a
useful way to improve the hemocompatibility in our previous
works.31,36 It has been found that the anticoagulant capacity is
closely associated with the retention of amount and bioactivity of
the immobilized BVLD. Thus, the effects of BVLD loading on NTs
(BVLD-NTs) and PDAM/NTs (BVLD-PDAM/NTs) for thrombin
adsorption and activity were investigated. Compared with at Ti,
NTs showed increase in the thrombin adsorption (Fig. S4A†) and
inhibited the activity of the adsorbed thrombin (Fig. S4B†). The
modication of PDAM to NTs further promoted thrombin
adsorption, and the activity of adsorbed thrombin was better
maintained on its surface. The loading of BVLD either to control
NTs or PDAM/NTs resulted in a substantial enhancement in
thrombin adsorption and suppression in thrombin activity. The
thrombin activity on the different surfaces was normalized to the
quantity of thrombin present on these surfaces to obtain a
specic thrombin activity (Fig. 4). Although PDAM coating on
NTs clearly accelerated thrombin activation, the further loading
of BVLD signicantly inhibited the thrombin activity and caused
the lowest thrombin activity per amount of adsorbed thrombin.
This indicates that BVLD loaded either on the control NTs or the
PDAM/NTs well retained its functionality as thrombin inhibitor.
Moreover, the signicantly prolonged clotting time (Fig. S5†)
conrmed the successful loading of BVLD and the excellently
maintained bioactivity.
The substantial inhibition of the thrombin activity by BVLD-
NTs and BVLD-PDAM/NTs also suggests potential effects on
preventing Fg activation and platelet activation/aggregation. ToFig. 4 Thrombin activity on the surfaces, normalized to the quantity of
thrombin present; ratio between activity (absorbance) and adsorbed
thrombin (mg cm2) (the size of sample: 1 cm  1 cm, n ¼ 4). Data
presented as mean  SD and analyzed using a one-way ANOVA, *p <
0.05, ***p < 0.001.
J. Mater. Chem. B, 2014, 2, 6767–6778 | 6771
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View Article Onlineattest this assumption, Fg adsorption and platelet adhesion
tests were carried out. As expected, both BVLD-NTs and BVLD-
PDAM/NTs remarkably suppressed Fg activation (Fig. S6†). SEM
images of platelet morphology also revealed a signicant
inhibitory effect of BVLD-NTs and BVLD-PDAM/NTs not only on
activation and aggregation but also on the adhesion of platelets
(Fig. 5A). As shown in Fig. 5, on the surfaces of the Flat Ti, most
of the adherent platelets were in an activated state with pseu-
dopodia. Although the formation of NTs and further modica-
tion by PDAM ad-layer did not make a signicant effect on the
number of adherent platelets (Fig. 5C), it stimulated the further
activation of the platelets (Fig. 5D) as evidenced by P-selectin
stainings (Fig. 5B). However, the loading of BVLD to NTs led to a
substantial decrease of both platelet adhesion and activation.
Importantly, the BVLD-PDAM/NTs showed considerably
stronger inhibition in platelet adhesion and activation due to
the increased amount of loaded BVLD. The platelets adhered on
BVLD-PDAM/NTs surface remained spherical and separated
without pseudopodia, which can be visually conrmed by
P-selectin stainings shown in Fig. 5B.Fig. 5 (A) Morphology of adherent platelets on the surfaces of various
staining, showing activated platelets labeled with a green fluorescent d
activated platelets on the flat Ti, NTs, PDAM/NTs, BVLD-NTs and BVLD-PD
least 12 SEM images. Data presented as mean  SD and analyzed using
6772 | J. Mater. Chem. B, 2014, 2, 6767–6778In the early stage of stent implantation, in addition to
thromboresistance, an anti-proliferative property against
smooth muscle cells is crucial to inhibit in-stent stenosis.
Therefore, the growth behavior of VSMCs on BVLD-PDAM/NTs
was investigated. Fig. 6A shows the typical uorescence micro-
scopic images of HUASMCs grown on different surfaces for 2 h,
1, 3 and 5 days. 2 h of cell culture revealed a signicant
reduction in the number of HUASMCs attached on the NTs
(45.9%) compared with the at Ti (Fig. 6B). In addition, the
HUASMCs attached on the NTs expressed the resting spherical
state and showed considerably smaller spreading areas than on
the at Ti. With increase in culture time, although HUASMCs
proliferated on both at Ti and NTs, the proliferation rate of
HUASMCs on NTs was much lower than on the at Ti (Fig. 6C).
These observations indicate a substantial inhibitory effect of
NTs on HUASMC attachment and spreading, cytoskeleton
development and proliferation.19 The loading of BVLD to the
NTs led to a further decrease in the number of adherent
HUASMCs, while there was no signicant effect on cell
morphology and proliferation. The introduction of PDAMsamples observed using SEM; (B) representative images of P-selectin
ye. (C) The number of the adhered platelets and (D) the ratio of the
AM/NTs (the size of sample: 1 cm 1 cm, n¼ 4) are calculated from at
a one-way ANOVA, **p < 0.01, ***p < 0.001.
This journal is © The Royal Society of Chemistry 2014
Fig. 6 (A) Fluorescent images of HUASMCs on Flat Ti, NTs, PDAM/NTs, BVLD-NTs and BVLD-PDAM/NTs surfaces (the size of sample: 1 cm  1
cm, n ¼ 4) after 2 h, 1, 3 and 5 days culture. (B) Amounts of HUASMCs attached onto Flat Ti, NTs, PDAM/NTs, BVLD-NTs and BVLD-PDAM/NTs
surfaces after 2 h culture, calculated from at least 12 images. (C) Proliferation of HUASMCs grown on Flat Ti, NTs, PDAM/NTs, BVLD-NTs and
BVLD-PDAM/NTs surfaces after 1, 3 and 5 days culture. Data presented as mean  SD and analyzed using a one-way ANOVA, *p < 0.05, **p <
0.01, ***p < 0.001.
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View Article Onlinead-layer at the NT coating stimulated HUASMC spreading,
which resulted in the enhanced proliferation of HUASMCs. This
may be attributed to the decreased diameter of the nanotubes or
the chemical cues of the PDAM ad-layer. The loading of BVLD
on PDAM/NTs reduced the HUASMC attachment and spreading
area. This suggests that BVLD facilitates the maintenance of the
differentiated state of HUASMCs, thus reinforcing the non-
proliferative phenotype. The reduced HUASMC proliferation
indirectly conrmed this deduction (Fig. 6C).This journal is © The Royal Society of Chemistry 2014The vessel tissue around the implant region is easily
damaged when the stent is expanded. This tissue trauma leads
to SMC migration and proliferation, and results in in-stent
restenosis. Therefore, the inhibition of SMC migration is
equally crucial in the early stage of stent implantation in the
form of SMC proliferation. Therefore, a test of SMC migration
was performed. As shown in Fig. 7, the NTs whether modied by
PDAM or loaded with BVLD strongly inhibited HUASMC
migration compared to at Ti. Both the migration distance andJ. Mater. Chem. B, 2014, 2, 6767–6778 | 6773
Fig. 7 Migration of HUASMCs on the Flat Ti, NTs, PDAM/NTs, BVLD-NTs and BVLD-PDAM/NTs surfaces (the size of sample: 0.8 cm  2.2 cm, n
¼ 6) after a culture of 1 day. (B) Themigration distance of migrated cells was calculated from at least 12 images. Data presented asmean SD and
analyzed using a one-way ANOVA, **p < 0.01, ***p < 0.001.
Fig. 8 (A) Cytoskeletal actin stains of HUVECs grown on Flat Ti, NTs, PDAM/NTs, BVLD-NTs and BVLD-PDAM/NTs surfaces (the size of sample: 1
cm  1 cm, n ¼ 4) after culture of 2 h, 1 and 3 days. (B) Amounts of HUVECs attached onto Flat Ti, NTs, PDAM/NTs, BVLD-NTs and BVLD-PDAM/
NTs surfaces after the culture of 2 h; calculated from at least 12 images. (C) Proliferation of HUVECs grown on Flat Ti, NTs, PDAM/NTs, BVLD-NTs
and BVLD-PDAM/NTs surfaces after cultures of 1 and 3 days. Data presented as mean SD and analyzed using a one-way ANOVA, *p < 0.05, **p
< 0.01, ***p < 0.001.
6774 | J. Mater. Chem. B, 2014, 2, 6767–6778 This journal is © The Royal Society of Chemistry 2014
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View Article Onlinedensity of the migrated HUASMCs on the control NTs, PDAM/
NTs, BVLD-NTs and BVLD-PDAM/NTs were considerably lower
than on the at Ti, suggesting a huge anti-restenotic potential.
Enhanced regeneration of a healthy endothelium is one of
the most important functionalities, which determines the
success of a vascular stent. The enhanced recruitment, migra-
tion, adhesion, spreading, viability, proliferation and the
expression of specic proteins and mediators by the ECs play
the important roles in endothelium regeneration. Thus, it is
very important to understand the interactions between the ECs
and the surface of an implanted material. A eukaryotic cell
adheres to a substrate generally during the process of attach-
ment, spreading, cytoskeleton development, and then prolifer-
ation.37 Therefore, the growth behavior of ECs on these
materials was systemically investigated.
Fig. 8A shows the typical uorescence microscopic images of
HUVECs. First, we studied the short-time attachment of
HUVECs. The statistical result revealed that the NTs surface
provided a better microenvironment for EC attachment than
the Flat Ti, which produced a signicant increase of 31.3% in
the number of attached cells (Fig. 8B). The PDAM ad-layer on
the NTs not only enhanced cell attachment but also stimulated
the cell spreading. This may be attributed to the effect of the
quinone/phenolic hydroxyl groups of PDAM ad-layer on fetal
bovine serum (FBS) adsorption.35 The loading of BVLD to the
bare NTs did not produce signicant effects on both cell
attachment and morphology compared to the control NTs.
Loading of BVLD to the PDAM/NTs, resulted in a 34.3% increase
in the number of adherent cells. The number of HUVECs
adherent on the BVLD-PDAM/NTs was 1.76-fold that on the Flat
Ti and 1.34-fold that on the control NTs. Most importantly,Fig. 9 (A) Migration of HUVECs on Flat Ti, NTs, PDAM/NTs, BVLD-NTs an
6) after 1 day culture. (B) The migration distance and (C) the density of mig
 SD and analyzed using a one-way ANOVA, *p < 0.05, **p < 0.01, ***p
This journal is © The Royal Society of Chemistry 2014HUVECs attached on the BVLD-PDAM/NTs still showed the
spreading state.
With increase in the culture time, the morphology of the
cells exhibited signicant differences. As reported, the
morphology development of ECs is closely related to the
expression of functional proteins and mediators, proliferation
and migration. Some previous studies have reported that
elongated cells are in a state of increased proliferation,38
extracellular matrix production19,21 and higher migration speed
compared to their spread counterparts.39 The analysis of cell
morphology, therefore, might help to gain an insight into the
interactions of the cells with substrates. The minor/major ratio
(aspect ratio, the value 0 for a straight line and 1 for perfectly
round) is an important index of cell morphology, where a lower
minor/major ratio of cell indicates a more extended cell. Thus,
the projected area of the cells and the aspect ratio of the
cultured cells aer 1 and 3 days were calculated. As expected,
the nanotopography of the NTs showed signicant effects on
directing cell morphology.19,21 The HUVECs grown on the NTs
exhibited a smaller projected area (Fig. S7A†) and more elon-
gated morphologies (as evidenced by the smaller aspect ratio of
the cells, Fig. S7C†) than HUVECs on the Flat Ti. It was found
that the projected area per cell increased but the aspect ratio of
the cells decreased with increasing culture time of the HUVECs.
This indicates that the cytoskeleton developed along the major
axis, and the increased projected area per cell was mainly
attributed to the increased length of the cells. Although loading
of BVLD to NTs preferred to induce some minor changes in the
projected area per cell and the aspect ratio of the cells, the
differences were not statistically signicant. The modication
of the NTs with the PDAM ad-layer led to a signicant increased BVLD-PDAM/NTs surfaces (the size of sample: 0.8 cm  2.2 cm, n ¼
rated cells; calculated from at least 12 images. Data presented as mean
< 0.001.
J. Mater. Chem. B, 2014, 2, 6767–6778 | 6775
Journal of Materials Chemistry B Paper
Pu
bl
is
he
d 
on
 1
1 
A
ug
us
t 2
01
4.
 D
ow
nl
oa
de
d 
by
 S
L
U
B
 D
R
E
SD
E
N
 o
n 
11
/4
/2
01
9 
10
:2
2:
00
 A
M
. 
View Article Onlinein the projected area per cell and aspect ratio of the cells. The
minor/major axis ratio of the cells on the PDAM/NTs was still
smaller than on the Flat Ti. The cells on BVLD-PDAM/NTs had
smaller aspect ratios than on PDAM/NTs, although their pro-
jected area was almost equal. Elongation of HUVECs was
observed at culture on plasma polymerized allylamine coating
covalently immobilized with BVLD.34 The cell area coverage on a
stent is crucial to the success of the re-endothelialization. The
statistical analysis of the cell area coverage revealed that theFig. 10 NO levels released in the culture media for Flat Ti, NTs, PDAM/
NTs, BVLD-NTs and BVLD-PDAM/NTs (the size of sample: 1.5 cm 1.5
cm, n ¼ 4). Data presented as mean  SD and analyzed using a one-
way ANOVA, *p < 0.05, **p < 0.01, ***p < 0.001.
Fig. 11 (A) Fluorescence staining of HUVECs (green) and HUASMCs (red)
surfaces (the size of sample: 1 cm  1 cm, n ¼ 4) after culture of 2 h. (B
images. (C) The ratio of the number of HUVECs to the number HUASMCs
*p < 0.05, **p < 0.01, ***p < 0.001.
6776 | J. Mater. Chem. B, 2014, 2, 6767–6778PDAM ad-layer played the key role in promoting cell coverage,
and the BVLD-PDAM/NTs showed the highest degree of cell area
coverage (Fig. S7B†). The statistical analysis of cell morphology
indicates that the BVLD-PDAM/NTs surface provides the best
microenvironment for cell attachment, spreading, and cyto-
skeleton development.
To attest the assumption based on the morphology analysis
of cells, proliferation, migration and the expression of specic
markers of the HUVECs were tested. As shown in Fig. 8C, 9 and
10, the NTs induced a considerable increase in proliferation,
migration and NO release of HUVECs as compared to the Flat
Ti. The modication by the PDAM ad-layer on the NTs further
enhanced cell proliferation, migration and NO release. The
loading of BVLD to NTs apparently promoted cell migration
better than cell proliferation or NO release. For the BVLD-
PDAM/NTs, the combination of dual chemical cues of PDAM ad-
layer and BVLD resulted in a substantial enhancement in cell
proliferation, migration and NO release. These observations
signicantly conrmed the analysis of cell morphology.
Migration of normal ECs into a lesion of the vessel wall has
been demonstrated to be an important way for the regeneration
of endothelium; enhanced EC motility may accelerate wound
healing aer injury or vascular stent implantation. However, the
ECs compete in vivo with SMCs. Thus, the efforts to partially
promote the EC growth (for instance, based on the EPC capture
for rapid re-endothelialization14,15) without considering the in
vivo competition with SMCs might be misleading and mean-
ingless.16,17 Therefore an ideal stent surface should havegrown onto Flat Ti, NTs, PDAM/NTs, BVLD-NTs and BVLD-PDAM/NTs
) Number of cells attached on the surfaces is calculated by at least 12
. Data presented as mean  SD and analyzed using a one-way ANOVA,
This journal is © The Royal Society of Chemistry 2014
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View Article Onlineselectivity for ECs and SMCs in a way that in situ formation of a
healthy endothelium on the stent is induced. Therefore, the test
of co-culture of HUVECs and HUASMCs was further carried out.
In this work, HUVECs and HUASMCs were seeded in a ratio of
1 : 1 in the competitive adhesion test. Fig. 11 shows the typical
uorescence images of HUVECs (green) and HUASMCs (red)
aer 2 h culture. On the Flat Ti surface, HUASMCs clearly
showed more signicant competitive adhesion than HUVECs,
the ratio of HUVECs/HUASMCs decreased to 0.49 (Fig. 11C).
However, NTs selectively promoted HUVEC adhesion while it
inhibited HUASMC adhesion. As shown in Fig. 11B, the number
of HUVECs adherence on the NTs was about 1.2-times higher
than on the Flat Ti, but the number of HUASMCs on the NTs
was only about 59.5% of that on the Flat Ti. The ratio of HUVECs
to HUASMCs of the NTs (1.01) was 2.1-times that of the Flat Ti
(Fig. 11C). The loading of BVLD to the NTs gave rise to a better
HUVEC selectivity and resulted in a higher ratio of HUVECs to
HUASMCs (1.24). For the PDAM/NTs, although the number of
the adherent HUASMCs increased compared with the NTs, the
ratio of HUVECs to HUASMCs (0.93) was close to that of the NTs
and was considerably higher than on the Flat Ti. This is
attributed to the signicant enhancement of PDAM/NTs in
HUVEC adhesion. In the case of the BVLD-PDAM/NTs, because
of the best promotion in HUVEC adhesion and considerable
promotion in HUASMC adhesion, the ratio of HUVECs to
HUASMCs reached 1.20 that was considerably higher than the
Flat Ti as well as NTs or PDAM/NTs. The excellent hemo-
compatibility and selective effects of BVLD-PDAM/NTs on
HUASMCs and HUVECs suggest the possibility to induce the in
situ formation of a pure endothelial layer and to address the
issues of restenosis and LST.
4. Conclusions
In this work, we have presented a simple surface modication
using a poly-dopamine ad-layer to tailor the surface function-
alities of TiO2 nanotube arrays. The TiO2 nanotube arrays
modied by polydopamine ad-layer not only showed a larger
capacity of bivalirudin (BVLD) loading than the control nano-
tube arrays but also exhibited a durable and controllable release
of BVLD. The combination of the biological functions of the
BVLD and the nanoscale cues of the TiO2 nanotube arrays
provided the multiple functions of improved hemocompati-
bility and selectivity for endothelial cells (EC) in a competitive
growth with vascular smooth muscle cells (VSMCs). These
results showed that our material provided an ideal microenvi-
ronment that is prone to promote the recovery of endothelium
on the luminal surface of a vascular stent and address the long-
term complications of restenosis and thrombosis. We believe
that this work might have the broad design philosophy of
vascular devices and arouse the development of a new genera-
tion of vascular stents.
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